LE
Legend Biotech
LEGN · NASDAQ
$20.49 -6.74% (-$1.48)
1M -0.82%
Market Cap $3.79B
P/E Ratio -
Div. Yield -
ROE 8.70%
Piotroski F-Score Weak
3/9Valuation
62 /100
Fair P/B 3.08x
P/S 2.98x
EV/FFO N/A
Growth
96 /100
Growing Book val. growth 10.42%
Rev. growth 106.41%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 4.42%
Gross margin 56.58%
FCF margin 20.10%
Quality
9 /100
Poor ROA 5.23%
ROIC 6.03%
Asset turnover 0.73x
Debt
69 /100
Low Int. coverage -2.59x
Debt/Equity 0.23x
Current ratio 3.04x
Stability
20 /100
Unstable EPS volatility 66.06%
Beta 0.40x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LEGN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alan S. Bash
Employees
3,200
Headquarters
Somerset
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report